ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,846.36
0.18%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Checkmate Pharmaceuticals Inc (CMPI)

  7. Checkmate Pharmaceuticals Inc (CMPI) Noticias

CMPI

Checkmate Pharmaceuticals (CMPI)

Checkmate Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CMPI
FechaHoraFuenteTítuloSímboloCompañía
10/06/202207:37Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMPICheckmate Pharmaceuticals Inc
07/06/202210:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
03/06/202210:42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202209:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202208:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202208:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202208:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202208:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202207:38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
26/05/202216:01GlobeNewswire Inc.University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
12/05/202215:50Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CMPICheckmate Pharmaceuticals Inc
12/05/202215:30GlobeNewswire Inc.Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CMPICheckmate Pharmaceuticals Inc
05/05/202215:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
02/05/202208:17Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CMPICheckmate Pharmaceuticals Inc
02/05/202206:49Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CMPICheckmate Pharmaceuticals Inc
29/04/202215:13Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
20/04/202205:02Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202222:45TipRanksAnalysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM) and Checkmate Pharmaceuticals (CMPI)NASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202215:51Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202208:46Dow Jones NewsCheckmate Pharmaceuticals Shares Take Flight on Regeneron DealNASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202206:47Dow Jones NewsRegeneron to Buy Checkmate Pharmaceuticals for About $250 MillionNASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202206:00PR Newswire (US)Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor TypesNASDAQ:CMPICheckmate Pharmaceuticals Inc
11/04/202222:15TipRanksCheckmate Pharmaceuticals (CMPI) Receives a Buy from BTIGNASDAQ:CMPICheckmate Pharmaceuticals Inc
08/04/202212:01GlobeNewswire Inc.Checkmate Pharmaceuticals Presents Clinical Trial Biomarker Data with Vidutolimod at the 2022 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
30/03/202206:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CMPICheckmate Pharmaceuticals Inc
29/03/202222:06TipRanksAnalysts’ Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Axsome Therapeutics (AXSM)NASDAQ:CMPICheckmate Pharmaceuticals Inc
29/03/202215:30GlobeNewswire Inc.Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business UpdateNASDAQ:CMPICheckmate Pharmaceuticals Inc
08/03/202215:30GlobeNewswire Inc.Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
02/03/202215:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CMPICheckmate Pharmaceuticals Inc
14/02/202210:57Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CMPICheckmate Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CMPI

Su Consulta Reciente

USOTC
RHHBY
Roche (QX)
NYSE
JPM
JP Morgan Chase
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
AMEX
XLE
Energy Select Sector SPDR
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
AMEX
XLV
Health Care Select Sector
FX
USDMXN
US Dollar vs MXN
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados